Please ensure Javascript is enabled for purposes of website accessibility
Contact us Contact Us
EN
Home > Featured Products > Oncology Research > Melanoma

960 product results for "Melanoma"

Options+
Options
Confirm
  • Product types
    0 selected
    Assay Kit (419)
    Biosimilars (1)
    Proteins (75)
    Research Biosimilar (157)
    Antibodies (298)
    Stable Cell Lines (1)
  • Expression system
    0 selected
    Mammalian Cells (185)
    E. coli (35)
    HEK293T (1)
  • Target
    0 selected
    Semaglutide (2)
    Cinpanemab (1)
    Tislelizumab (1)
    Pacmilimab (1)
    CD274/PD-L1 & CD152/CTLA4 (1)
    CD223/LAG3 & CD279/PD-1 (4)
    Ifabotuzumab (1)
    Siltuximab (3)
    gD/US6 (1)
    Elezanumab (1)
    Etanercept (3)
    NP/Nucleoprotein (3)
    CD20/MS4A1 (3)
    Secukinumab (2)
    Foravirumab (1)
    Elotuzumab (1)
    Ontamalimab (1)
    Eculizumab (3)
    Talacotuzumab (1)
    Tirzepatide (2)
    Pasotuxizumab (1)
    Mirzotamab (1)
    M1R (5)
    Losatuxizumab (1)
    Spike glycoprotein (RBD) (1)
    CD274/PD-L1 & CD28 & CD152/CTLA4 (1)
    Epcoritamab (1)
    Fluorescein & CD274/PD-L1 (1)
    Ibalizumab (1)
    S100a15a (1)
    Tocilizumab (3)
    Inclacumab (1)
    S100P (1)
    Human β Amyloid (1-40) (1)
    Cergutuzumab (1)
    KITLG/SCF (1)
    CD47/MER6 & PDCD1 / PD-1 / CD279 (1)
    Lorvotuzumab (1)
    Lintuzumab (1)
    TPP17 (1)
    Otilimab (1)
    Zagotenemab (1)
    IDO1 (2)
    CD274/PD-L1 & CD28 (1)
    T-cell surface glycoprotein CD3 epsilon chain (1)
    Figitumumab (1)
    Farletuzumab (1)
    S100A1 (2)
    SOX10 (3)
    S100A12 (1)
    Oxelumab (1)
    Evolocumab (1)
    CD366/TIM-3 & CD274/PD-L1 (1)
    Toripalimab (1)
    CD279/PD-1 & CD152/CTLA4 (4)
    Denosumab (3)
    US8/gE (1)
    Sibrotuzumab (1)
    HLA-A2-peptide (TDQVPFSV) Complex (1)
    RBD (6)
    RBD (Omicron/JN.1) (1)
    Codrituzumab (1)
    Mazdutide (2)
    NRAS (2)
    Rafivirumab (1)
    RBD (WT) (1)
    CD274/PD-L1 & TGFBR2 (1)
    Meplazumab (1)
    Mirikizumab (2)
    Aflibercept (1)
    Vibecotamab (1)
    Glycoprotein G (2)
    GP/Envelope glycoprotein (4)
    Rosopatamab (2)
    TYR/Tyrosinase (2)
    Omburtamab (1)
    Necitumumab (1)
    Zenocutuzumab (1)
    CD274/PD-L1/B7-H1 (5)
    Glofitamab (1)
    Ieramilimab (1)
    S100A13 (1)
    Tregalizumab (1)
    TRP-1 & CD47/MER6 (1)
    Adalimumab (3)
    S100A2 (1)
    TAU pT181 (1)
    Labetuzumab (1)
    B7-H1 / PD-L1 / CD274 & CD3E (1)
    Faricimab (1)
    TPP47 (1)
    TDP2 (1)
    Asp f 1/mitF (1)
    MITF (1)
    CD223 (1)
    Edrecolomab (1)
    S100A11 (2)
    S100A16 (1)
    Canakinumab (1)
    MLANA (4)
    Ganitumab (1)
    Mirvetuximab (1)
    H3L (3)
    Alirocumab (1)
    CD137/4-1BB & CD274/PD-L1 (3)
    CD79B (2)
    S100A8 (3)
    Nirsevimab (1)
    CD223/LAG3 & CD152/CTLA4 (1)
    Cetuximab (3)
    Letolizumab (1)
    Imlifidase (5)
    Spike glycoprotein E2 (2)
    Enfortumab (1)
    RBD (Delta) (3)
    Dupilumab (3)
    RBD (Omicron/KP.2) (1)
    Tibulizumab (1)
    HLA-A2-peptide (ITDQVPFSV) Complex (4)
    RBD (Alpha) (1)
    p-Tyr (1)
    Glembatumumab (1)
    gG/US4 (2)
    PMEL17/ME20M (9)
    Tarextumab (1)
    VASH2/Vasohibin-2 (1)
    Bevacizumab (3)
    Panitumumab (3)
    EPO/Erythropoietin (1)
    cAMP (1)
    Ibritumomab (1)
    Benufutamab (1)
    Zanolimumab (1)
    Lacnotuzumab (1)
    Olaratumab (1)
    TRP-1 & CD134/OX40 (1)
    TAU pT217 (1)
    Tisotumab (1)
    Oleclumab (1)
    Nesvacumab (1)
    G/Major surface glycoprotein G (1)
    Milatuzumab (1)
    Befovacimab (1)
    VSIR/VISTA & CD274/PD-L1 (1)
    Gevokizumab (1)
    Teprotumumab (1)
    gB/Envelope glycoprotein B (1)
    Omalizumab (2)
    Frovocimab (1)
    E8L (5)
    CD274/PD-L1 & CD279/PD-1 (1)
    Palivizumab (3)
    CD47/MER6 & CD274/PD-L1 (2)
    sCD14 (1)
    Simlukafusp Alfa (1)
    Spike glycoprotein (10)
    CD340/ERBB2 (1)
    Astegolimab (1)
    LAG3 & PD-1 (1)
    Vunakizumab (1)
    HLA-A2-peptide (YLEPGPVT) Complex (4)
    Tosatoxumab (1)
    CD152/CTLA4 & CD279/PD-1 (1)
    RBD (Beta) (1)
    CD137/4-1BB & CD274/PD-L1 & ROR1 & CD3 (1)
    Alacizumab (1)
    Balstilimab (1)
    Dilpacimab (1)
    Natalizumab (2)
    Exenatide acetate (2)
    CD278/ICOS (1)
    Brolucizumab (1)
    Serclutamab (1)
    S100B (9)
    Clazakizumab (1)
    S100A9 (4)
    Mosunetuzumab (1)
    Mavezelimab (1)
    CD80/B7-1 (20)
    Conatumumab (1)
    Tovetumab (1)
    CD279/PD-1 & CD274/PD-L1 (1)
    Certolizumab (2)
    Calprotectin (S100A8/9) (3)
    Cabiralizumab (1)
    CD47/MER6 & PDCD1 / PD-1 & CD137/4-1BB/TNFRSF9 (1)
    CD152/CTLA4 & CD274/PD-L1 (1)
    Vanucizumab (1)
    N/Nucleoprotein (1)
    PD-L1 & VEGF (1)
    Concizumab (1)
    Rolinsatamab (1)
    Bimagrumab (1)
    gE/Envelope glycoprotein E (1)
    CD175/Tn (10)
    Urelumab (1)
    Lodelcizumab (1)
    A35R (5)
    CD366/TIM-3 & CD279/PD-1 (2)
    Ustekinumab (3)
    Ivuxolimab (1)
    Afasevikumab (1)
    Suptavumab (1)
    F/Fusion glycoprotein F0 (5)
    Itolizumab (1)
    Ianalumab (1)
    CD274/PD-L1 & SLT-Ia (1)
    Spike Protein (Trimer) (2)
    Iscalimab (1)
    IL1RL1/ST2 (1)
    mitF/aspF1 (1)
    HLA-A2-peptide (KTWGQYWQV) Complex (2)
    RBD (Gamma) (1)
    Ramucirumab (1)
    Cetrelimab (1)
    Navicixizumab (1)
    CD80/B7-1 & CD86/B7-2 (2)
    Basiliximab (1)
    Apamistamab (1)
    CD117/KIT (24)
    Ranibizumab (3)
    CD274/PD-L1 (81)
    CD366/TIM-3 (34)
    cGMP (1)
    Olokizumab (1)
    Ocaratuzumab (1)
    Favezelimab (1)
    CD86/B7-2 (26)
    Drozitumab (1)
    Spike glycoprotein E1 (2)
    Eldelumab (1)
    Sacituzumab (1)
    PDL1 & VEGF (1)
    CD274/PD-L1 & CD3E (1)
    CD3E (1)
    Emactuzumab (1)
    Imalumab (1)
    Zampilimab (1)
    CD80&IL2 (1)
    Disitamab (1)
    Marstacimab (1)
    Atezolizumab (3)
    Sotrovimab (1)
    Retatrutide (1)
    gD/Envelope glycoprotein D (1)
    Utomilumab (1)
    A29L (6)
    EGFR & CD3E & PD-L1 & 4-1BB (1)
    B6R/SL-159 (1)
    Pogalizumab (1)
    Bimekizumab (1)
    Guselkumab (3)
    Amatuximab (1)
    CD274/PD-L1 & VEGFA (1)
    NP/Nucleocapsid (5)
    dsDNA (1)
    Belantamab (1)
    Tiragolumab (2)
    Obiltoxaximab (1)
    CD19 & PD-L1 & CD3E & CD137 (1)
    FLT1/VEGFR1 & CD274/PD-L1 (1)
    RBD (E484K) (1)
    Nivolumab (3)
    Anifrolumab (1)
    Camidanlumab (1)
    Varisacumab (1)
    Tesidolumab (1)
    BSA (1)
    Sirukumab (1)
    VEGFA & B7-H1 / PD-L1 / CD274 (1)
    BRAF/B-Raf (5)
    TYR (1)
    Abatacept (1)
    Lexatumumab (1)
    dsRNA (1)
    Ipilimumab (2)
    CD274/PD-L1 & CD47/MER6 (1)
    gp100 peptide-HLA Complex (1)
    Golimumab (3)
    CD47/MER6 & CD274/PD-L1/B7-H1 (2)
    CD223/LAG3 (41)
    CD152/CTLA4 & CD134/OX40 (1)
    Lupartumab (1)
    Pertuzumab (3)
    TFF3 (1)
    Pembrolizumab (3)
    Avelumab (3)
    CD152/CTLA4 (86)
    Casirivimab (1)
    Daratumumab (3)
    β-D-Glucan (1)
    gC/Envelope glycoprotein C (1)
    Tezepelumab (1)
    IL6 (1)
    SARS-CoV-2 Neutralization Antibody (3)
    Tavolimab (1)
    TIGIT & CD274/PD-L1 (1)
    Ixekizumab (1)
    Suvizumab (1)
    RBD (Omicron/BA.4/BA.5) (1)
    Cusatuzumab (1)
    Anetumab (1)
    Blosozumab (1)
    CD274/PD-L1 & TGFBR2/TGFR-2 (1)
    Varlilumab (1)
    Glycoprotein (5)
    Teclistamab (1)
    Sarilumab (2)
    RBD (Kappa) (1)
    Ascrinvacumab (1)
    PD-L1 & TGF-Beta (1)
    Obinutuzumab (2)
    PD-L1 / VEGF-A (1)
    Daclizumab (1)
    Emibetuzumab (1)
    Protein A (1)
    Ziltivekimab (1)
    Carlumab (1)
    Indatuximab (1)
    Tigatuzumab (1)
    ATP7B (1)
    S100A14 (1)
    Lenzilumab (1)
    Semorinemab (1)
    Tremelimumab (1)
    CD274/PD-L1 & CD134/OX40 (1)
    T3E (1)
    S100A5 (4)
    Cixutumumab (1)
    Andecaliximab (1)
    Vofatamab (1)
    Trastuzumab (2)
    Sintilimab (1)
    Durvalumab (3)
    Imdevimab (1)
    S100A4 (3)
    gC/UL44 (1)
    Magrolimab (1)
    RBD (Omicron/BA.5) (3)
    Lirilumab (1)
    Remtolumab (1)
    Vorsetuzumab (1)
    DCT (2)
    Romosozumab (1)
    CD274/PD-L1 & CD137/TNFRSF9 (1)
    Romiplostim (2)
    M/Matrix protein (2)
    Rituximab (1)
    Enoblituzumab (1)
    TYRP1 (3)
    Gremubamab (1)
    RBD (Delta Plus) (1)
    CD137/4-1BB/TNFRSF9& CD274/PD-L1/B7-H1 (1)
    Zanidatamab (1)
    Afutuzumab (1)
    Icrucumab (1)
    CD366/HAVCR2/TIM-3 (4)
    PDL1 (6)
    Crizanlizumab (1)
    TRP-1 & CD3e (1)
    Tanezumab (1)
    Human β Amyloid (1-42) (1)
    S100A6 (1)
    LAG-3 & PD-1 (1)
    S100A10 (4)
    TPP15 (1)
    Namilumab (1)
    Tilavonemab (1)
    CTLA4 & PD1 (2)
    Zalifrelimab (1)
    T-cell surface antigen T3/Leu-4 epsilon chain (1)
    Infliximab (2)
    Dalotuzumab (1)
    Depatuxizumab (1)
  • Species
    0 selected
    Mus musculus (Mouse) (7)
    Tupaia chinensis (12)
    Canis lupus familiaris (Dog) (8)
    Homo sapiens (Human) (7)
    Neosartorya fumigata (1)
    Human (177)
    Dog (3)
    Felis catus (Cat) (9)
    Canis lupus familiaris (1)
    Cat (1)
    Mouse (24)
    Rat (1)
  • Applications
    0 selected
    Immunogen (75)
    IP (2)
    SPR (4)
    FuncS (18)
    Research in vivo (158)
    in vivo PD-L1 blockade (3)
    Bioactivity testing in progress (31)
    Neut (1)
    IFA (4)
    in vitro PD-L1 blockade (3)
    ELISA (844)
    Inhib (1)
    FACS (5)
    GICA (2)
    IHC-F (3)
    IHC (84)
    Functional assay (6)
    WB (165)
    Neutralization (2)
    IF (8)
    in vivo CTLA-4 neutralization (2)
    Bioactivity: FACS (1)
    Research in vivo (4)
    FCM (152)
    in vivo intra-tumoral regulatory T cell depletion (2)
    Bioactivity: FACS (153)
    in vivo blockade (2)
    in vivo (2)
    SDS-PAGE (75)
    Blocking (2)
    Functional assay (158)
  • Reactivity
    0 selected
    Bos taurus (8)
    Mesocricetus auratus (1)
    Neosartorya fumigata (1)
    Cavia porcellus (1)
    Broad-Spectrum (1)
    Monkey (5)
    Oryctolagus cuniculus (4)
    Monodelphis domestica (1)
    Cyprinus carpio (1)
    Callithrix jacchus (1)
    Avian retrovirus IC10 (1)
    Oryzias latipes (1)
    B7-H1 / PD-L1 / CD274 (1)
    Danio rerio (1)
    Capra hircus (1)
    Avian rous-associated virus type 1 (1)
    Cynomolgus monkey (1)
    Xenopus laevis (1)
    Drosophila grimshawi (1)
    Mus musculus (Mouse) (1)
    Drosophila willistoni (1)
    Coturnix japonica (1)
    Rhesus macaque (1)
    Bovine (1)
    Kirsten murine sarcoma virus (1)
    Cat (1)
    Dog (13)
    Chicken (4)
    Homo sapiens (Human) (4)
    Kryptolebias marmoratus (1)
    Pig (6)
    Macaca mulatta (1)
    Mouse (81)
    Rat (16)
    Tupaia chinensis (4)
    Limanda limanda (1)
    Carassius auratus (1)
    Pongo abelii (2)
    Human (199)
  • Host species
    0 selected
    Armenian Hamster (5)
    Rat (14)
    Humanized (34)
    Dog (2)
    Mouse (164)
    Chimeric (5)
    Alpaca (6)
    Rabbit (61)
    HEK293T (1)
    Human (157)
  • Clonality
    0 selected
    Monoclonal (398)
    Polyclonal (53)
  • Conjugate
    0 selected
    Unconjugated (301)
    FITC (28)
    APC (28)
    PerCP (28)
    PE (28)

Quick access

Contact Us

  • +86-27-65523339

  • info@abinscience.com

  • Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China

  • linkedin
  • Ins
  • youtube
  • youtube
Copyright © 2026 abinScience. All Rights Reserved. All Products are for Research Use Only